The origin of ovarian cancer

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 119, Issue 2, 2012, Pages 134-136

  Ahmed, A A ^a   Becker, C M ^a   Bast, R C ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; DNA; PROTEIN P53; TRANSCRIPTION FACTOR HOXA10; TRANSCRIPTION FACTOR HOXA11; TRANSCRIPTION FACTOR HOXA9; UNCLASSIFIED DRUG;

CANCER GRADING; CANCER INVASION; CANCER RISK; DNA DAMAGE; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; GENE MUTATION; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; MUELLERIAN DUCT; NONHUMAN; NOTE; OVARY CANCER; OVARY CYST; POSTMENOPAUSE; PRIORITY JOURNAL; PROBABILITY; PROSPECTIVE STUDY; SALPINGOOOPHORECTOMY;

EID: 83655202977     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2011.03149.x     Document Type: Note

References (12)

1. Hamilton TC,. Ovarian cancer, Part I: biology. Curr Probl Cancer 1992; 16: 1-57.
2. Cheng W, Liu J, Yoshida H, Rosen D, Naora H,. Lineage infidelity of epithelial ovarian cancers is controlled by HOX genes that specify regional identity in the reproductive tract. Nat Med 2005; 11: 531-7. (Pubitemid 40685976)
3. Dubeau L,. The cell of origin of ovarian epithelial tumors and the ovarian surface epithelium dogma: does the emperor have no clothes? Gynecol Oncol 1999; 72: 437-42. (Pubitemid 29118208)
4. Piek JM, van Diest PJ, Zweemer RP, Kenemans P, Verheijen RH,. Tubal ligation and risk of ovarian cancer. Lancet 2001; 358: 844.
5. Ahmed AA, Etemadmoghadam D, Temple J, Lynch AG, Riad M, Sharma R, et al., Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary. J Pathol 2010; 221: 49-56.
6. The Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature 2011; 474: 609-15.
7. Finch A, Shaw P, Rosen B, Murphy J, Narod SA, Colgan TJ,. Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers. Gynecol Oncol 2006; 100: 58-64. (Pubitemid 41815050)
8. Medeiros F, Muto MG, Lee Y, Elvin JA, Callahan MJ, Feltmate C, et al., The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. Am J Surg Pathol 2006; 30: 230-6. (Pubitemid 43740193)
9. Dinulescu DM, Ince TA, Quade BJ, Shafer SA, Crowley D, Jacks T,. Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer. Nat Med 2005; 11: 63-70. (Pubitemid 40215839)
10. Kindelberger DW, Lee Y, Miron A, Hirsch MS, Feltmate C, Medeiros F, et al., Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship. Am J Surg Pathol 2007; 31: 161-9. (Pubitemid 46175016)
11. Roh MH, Yassin Y, Miron A, Mehra KK, Mehrad M, Monte NM, et al., High-grade fimbrial-ovarian carcinomas are unified by altered p53, PTEN and PAX2 expression. Mod Pathol 2010; 23: 1316-24.
12. Connolly DC, Bao R, Nikitin AY, Stephens KC, Poole TW, Hua X, et al., Female mice chimeric for expression of the simian virus 40 TAg under control of the MISIIR promoter develop epithelial ovarian cancer. Cancer Res 2003; 63: 1389-97. (Pubitemid 36348722)